Efecto inhibitorio de un extracto acuoso de las hojas de Allophylus cominia (L.) Sw sobre las proteínas tirosina fosfatasa 1B y dipeptidil peptidasa IV by Sánchez Calero, Janet et al.
Strathprints Institutional Repository
Sánchez Calero, Janet and Young, Louise C. and Marrero Faz, 
Evangelina and L. Harvey, Alan (2014) Efecto inhibitorio de un extracto 
acuoso de las hojas de Allophylus cominia (L.) Sw sobre las proteínas 
tirosina fosfatasa 1B y dipeptidil peptidasa IV. Revista Cubana de 
Farmacia, 48 (4). pp. 672-683. ISSN 1561-2988 , 
This version is available at http://strathprints.strath.ac.uk/57822/
Strathprints is  designed  to  allow  users  to  access  the  research  output  of  the  University  of 
Strathclyde. Unless otherwise explicitly stated on the manuscript, Copyright © and Moral Rights 
for the papers on this site are retained by the individual authors and/or other copyright owners. 
Please check the manuscript for details of any other licences that may have been applied. You 
may  not  engage  in  further  distribution  of  the  material  for  any  profitmaking  activities  or  any 
commercial gain. You may freely distribute both the url (http://strathprints.strath.ac.uk/) and the 
content of this paper for research or private study, educational, or not-for-profit purposes without 
prior permission or charge. 
Any  correspondence  concerning  this  service  should  be  sent  to  Strathprints  administrator: 
strathprints@strath.ac.uk
Revista Cubana de Farm acia. 2 0 1 4 ;4 8 ( 4 ) :6 7 2 - 6 8 3  

KWWSVFLHORVOGFX
672
PRODUCTO NATURAL

I nhibitory effect  of Allophylus com inia  ( L.)  Sw  leaves 
aqueous extract  on tyrosine phosphatase 1 B and 
dipept idyl pept idase I V proteins 

Efecto inhibitor io de un ext racto acuoso de las hojas de 
Allophylus com inia  ( L.)  Sw  sobre las proteínas t irosina 
fosfatasa 1 B y dipept idil pept idasa I V  


DraC. Janet  Sánchez Calero, I  Lic. Louise C. Young, I I  DrC. Evangelina 
Marrero Faz, I  Ph.D Alan L Harvey I I  
I National Centre for Animal and Plant Health (CENSA), San José de las Lajas, 
Mayabeque, Cuba. 
II Strathclyde Institute for Pharmaceutical and Biomedical Sciences (SIPBS) / 
University of Strathclyde, Glasgow, Scotland, United Kingdom. 



ABSTRACT 
I nt roduct ion: Allophylus com inia (L.) Sw is a Cuban medicinal plant used by 
traditional medicine for the treatment of diabetes with unknown mechanisms of 
action. 
Object ive: to evaluate the effect of Allophylus com inia (L.) Sw leaves aqueous 
extract and its fractions on protein tyrosine phosphatase 1B (PTP1B) and dipeptidyl 
peptidase IV (DPPIV) enzymatic activity, as therapeutic targets of type 2 diabetes. 
Methods: the aqueous extract of A. com inia leaves was successively partitioned 
with organic solvents mixtures, thus increasing polarity in order to obtain ten 
fractions. The extract and its fractions were tested for their possible antidiabetic 
activity on therapeutic targets of type 2 diabetes: PTP1B and DPPIV. The enzymatic 
inhibition assays were performed and the inhibitory activity was calculated with the 
fluorescence values using an excitation wavelength of 360 nm and an emission 
wavelength of 460 nm. 
Results: the aqueous extract from A. com inia inhibited the enzymatic activity of 
PTP1B and DPPIV according to the concentration, being IC50 values equal to  
0.69 ǋg/mL and 344.3 ǋg/mL, respectively. Several fractions were detected as 
potent PTP1B inhibitors. The most polar fractions AcF9 and AcF10 were more 
active, showing IC50 values of 4.4 µg/mL and 3.8 µg/mL respectively. The fractions  
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showed a slight DPPIV inhibition, being fractions AcF6, AcF9 and AcF10 the most 
active, exhibiting inhibition percentages of 52.0 %, 39.0 % and 40.0 % 
respectively. 
Conclusions: A. com inia aqueous extract and its polar fractions (AcF9 and AcF10) 
have antidiabetic properties in vitro and are promissory candidates for development 
of new drugs with inhibitory activity of PTP1B and DPPIV for type 2 diabetes 
treatment. 
Keyw ords: Allophylus com inia (L.) Sw, antidiabetic activity, PTP1B inhibitors, 
DPPIV inhibitors, type 2 diabetes therapeutic targets. 

RESUMEN  
I nt roducción: Allophylus com inia (L.) Sw es una planta medicinal cubana usada 
por la medicina tradicional para el tratamiento de la diabetes, cuyo mecanismo de 
acción es desconocido. 
Objet ivo: evaluar el efecto del extracto acuoso de hojas de A. com inia (L.) Sw y 
sus fracciones sobre la proteína tirosina fosfatasa 1B (PTP1B) y dipeptidil peptidasa 
IV (DPPIV) como diana terapéuticas para el tratamiento de la diabetes tipo 2. 
Métodos: el extracto acuoso de hojas de A. com inia fue fraccionado sucesivamente 
con mezclas de solventes orgánicos, incrementando la polaridad, para obtener diez 
fracciones. El extracto y sus fracciones fueron evaluados para su posible actividad 
antidiabética sobre diana terapéuticas de diabetes tipo 2: PTP1B y DPPIV.  
Se realizaron ensayos de inhibición enzimática y la actividad inhibitoria se calculó a 
partir de los valores de fluorescencia, empleando longitudes de onda de excitación 
y de emisión de 360 nm y 460 nm respectivamente. 
Resultados: el extracto acuoso de A. com inia inhibió la actividad enzimática de 
PTP1B y DPPIV de manera dependiente de la concentración, con valores de CI50 de 
0,69 ǋg/mL y 344,3 ǋg/mL respectivamente. Varias fracciones se detectaron como 
potentes inhibidores de PTP1B. Las fracciones más polares AcF9 y AcF10 fueron las 
más activas, y mostraron valores de CI50 de 4,4 µg/mL y 3,8 µg/mL 
respectivamente. Las fracciones mostraron una ligera inhibición de DPPIV, y las 
más activas resultaron AcF6, AcF9 y AcF10, con valores de porcentajes de 
inhibición de 52,0 %, 39,0 % y 40,0 % respectivamente. 
Conclusiones: el extracto acuoso de A. com inia y sus fracciones polares (AcF9 y 
AcF10) tienen propiedades antidiabéticas in vit ro y son candidatos promisorios para 
el desarrollo de nuevos medicamentos con actividad inhibidora de PTP1B y DPPIV 
para el tratamiento de la diabetes tipo 2. 
Palabras clave: Allophylus com inia (L.) Sw, actividad antidiabética, inhibidores de 
PTP1B, inhibidores de DPPIV, diana terapéuticas de diabetes tipo 2.



I NTRODUCTI ON  
Diabetes mellitus is a metabolic disorder of multiple etiologies characterized by 
chronic hyperglycemia and altered metabolism of lipids, carbohydrates and 
proteins, due to defects in insulin secretion and /or insulin action.1 
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Protein tyrosine phosphatase 1B (PTP1B) has been implicated in the negative 
regulation of insulin signaling by dephosphorylating the insulin receptor (IR) as well 
as its substrate, insulin receptor substrate-1 (IRS-1) and insulin receptor substrate-
2 (IRS-2), and selective inhibition of PTP1B has emerged as a potential drug target 
for the treatment of type 2 diabetes.2 
Dipeptidyl peptidase IV (DPPIV) is a serine protease, which causes breakdown of 
the peptides that containing proline or alanine as the second residue. The most 
important substrate for this enzyme are incretin hormones such as: glucagon-like 
peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which 
are released into the intestine in response to nutrient ingestion and stimulate 
insulin secretion induced by glucose.3 Thus, GLP-1 stimulates insulin biosynthesis 
and secretion, reduces glucagon release, slows gastric emptying, reduces appetite 
and stimulates the regeneration and differentiation of Langerhans islets of ǃ cells.4 
Moreover, GIP is involved in glucose metabolism by increasing insulin secretion.5 
Both peptides have short half-lives due to rapid degradation by protease DPPIV. 
DPP-IV inhibitors are a new class of oral anti-hyperglycemic agents, whose effect is 
mediated through the incretin hormones. Thus, the inhibition of DPPIV enzymatic 
activity, prolongs the action of GLP-1 and GIP, which maintain glucose homeostasis. 
Hence, DPP-IV inhibition has the potential to be a novel, efficient and tolerable 
approach to treat type 2 diabetes.6 
Allophylus com inia (L.) Sw (Sapindaceae), also known as Rhus com inia (L.) or 
Schm idelia com inia Sw, which common name is palo de caja, caja or caja com ún, is 
one of the most well-known medicinal plant in Cuba.7 It was initially used as a 
remedy against gastrointestinal disorders, but was subsequently employed as a 
remedy for diabetes. It has also been reported in the use of tuberculosis and 
catarrhal diseases in general. In addition, medicinal properties against toothache 
and use as a blood purifier in venereal diseases have also been attributed to this 
plant.7 
Several investigations have reported the hypoglycaemic activity of A. com inia 
aqueous extracts in normoglycaemic and type 1 diabetic animals models.8-10 
The phytochemical studies of the aqueous extract of leaves from A. com inia 
revealed the presence of tannins, free amines, phenols, triterpenes and steroids.  
In addition, in this extract proteins, carbohydrates such as arabinose, xylose, 
galactose, glucose and fatty acids (lauric, miristic, palmitic, estearic and 
arachidonic) were identified.11 
The aim of the study was to investigate the inhibitory effect on PTP1B and DPPIV of 
A com inia leaves (aqueous extract and its fractions) as the underlying mechanism 
to the potential type 2 anti-diabetic properties of this plant. 

METHODS
PLANT MATERIAL
Allophylus com inia (L.) Sw (Sapindaceae) leaves were collected from forest of 
Cotilla (San José de Las Lajas, Mayabeque, Cuba) in the month of February (2008). 
Plants were taxonomically authenticated by Prof. Fernando Franco Flores, in the 
Laboratory of Botany at the Agriculture University of Havana, Cuba. A voucher 
specimen of the plant is kept for reference (HFA-1769) in the Herbarium of this 
institution. 
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PLANT EXTRACT 
Fresh leaves of A. com inia were dried in a stove at 37 °C for 96 h. The dry leaves 
were milled in fine particles of 5 mm. The plant extract was obtained from powder 
aqueous extraction at 95 °C for 30 min, in a 10 % (w/v) relation. The resulting 
extract was freeze dried. Dry extract was stored in plastic bottles in a desiccator for 
future experiments. 
 
FRACTIONATION OF PLANT EXTRACT
Ten fractions were obtained from A. com inia aqueous extract using a Flash 
Chromatography System. It was used 5 g of dried extract in adsorption 
chromatography employing a column (Isolute Flash, Si, 100 g) and as mobile 
phase, an organic solvents mixture, from low to high polarity (n-hexane;  
1,2 di-chloro-metane; 2-butanol; methanol and water). Elution was achieved using 
solvent gradients of 400 mL aliquots of n-hexane 100 % (AcF1), 1,2 di-chloro-
metane 100 % (AcF2), 1,2 di-chloro-metane 75 %: 2-butanol 25 % (AcF3),  
1,2 di-chloro-metane 50 %: 2-butanol 50 % (AcF4), 1,2 di-chloro-metane 25 %:  
2-butanol 75 % (AcF5), 2-butanol 100 % (AcF6), 2-butanol 75 %: methanol 25 % 
(AcF7), 2-butanol 50 %: methanol 50% (AcF8), 2-butanol 25 %: methanol 75 % 
(AcF9) and methanol 50 %: water 50 % (AcF10). 
 
PROTEIN TYROSINE PHOSPHATASE 1B (PTP1B) ENZYME ASSAY
The assay was performed as previously described, in 96-well black microplates.12 
PTP1B (human, recombinant, Sigma) was incubated in the presence and absence of 
A. com inia extract and its fractions. 
For inhibition assay, 25 L of different concentrations of A. com inia aqueous extract 
and its fractions (0.01-300 µg/mL), the standard inhibitor [Bis(4-
Trifluoromethylsulfonamidophenyl)-1,4-diisopropylbenzine] (TFMS, Calbiochem) 
(0.1-300 µM) or buffer solution (pH 7.2), containing the following reagents at final 
concentrations indicated: Hepes (25 mM), sodium chloride (50 mM), Dithiothreitol 
(2 mM), ethylene-diamine-tetraacetic acid (EDTA) (2.5 mM) and Bovine Serum 
Albumin (BSA) (0.01 mg/mL), were pre-incubated with 50 µL of enzyme for 30 min 
at 37 ºC. Subsequently, 25 µL of substrate (6.8-difluoro-4-methylumbelliferyl 
phosphate) (DiFMUP, Invitrogen Ltd.), at a final concentration of 10 µM, was added 
to the reaction mixture and was placed in a 37 ºC incubator for 10 min.  
The amount of end product (umbelliferone) obtained was measured by determining 
change in fluorescence on a Wallac Victor 2 (Perkin-Elmer, Sunnyvale, CA) using an 
excitation wavelength of 360 nm and an emission wavelength of 460 nm. 
 
DIPEPTIDYL PEPTIDASE IV (DPPIV) ENZYME ASSAY 
The assay was performed as previously described, in black 96-well microtitre 
plates.13 DPPIV (human, recombinant, Sigma) was incubated in the presence and 
absence of A. com inia extract and its fraction. 
For inhibition assays, 25 µL of different concentrations of aqueous extract from A. 
com inia (0.01-300 µg/mL) and its fractions (100 µg/mL), the standard inhibitor 
[(3N-[(2S, 3S)-2-amino-3-methyl-pentanoyl]-1,3-thiazolidine) hemifumarate] (P32/98) 
(0.1-300 µM) or buffer solution (pH 8.00), containing the following chemicals at final 
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concentrations indicated: Tris-HCl (100 mM) with Bovine Serum Albumin (BSA)  
(0.1 mg/mL), were preincubated with 50 µL of enzyme (final concentration: 0.3 nM) for 
30 min at 37 ºC. After 25 mL of substrate [Gly-Pro-7-amido-4-methylcoumarin 
hydrobromide] (Gly-pro-AMC), at final concentration of 30 µM, was added to reaction 
mixture and it was placed in a 37 ºC incubator for 30 min. The amount of end product 
(umbelliferone) obtained was estimated by measuring change in fluorescence on a 
Wallac Victor 2 (Perkin-Elmer, Sunnyvale, CA) using an excitation wavelength of 355 nm 
and an emission wavelength of 460 nm. 
The percentage inhibition of PTP1B and DPPIV was calculated as follows: [Enzyme 
in the presence of compound (random fluorescent units)/Enzyme in the absence of 
compound (random fluorescent units)]*100. 
 
STATISTICAL ANALYSIS 
The IC50 value for each compound was calculated by non-linear regression analysis 
using GraphPad Prism version 4.03 -2005 (La Jolla, California, USA) subsequently, 
the apparent Ki of the substrate was calculated for each sample using the Cheng-
Prusoff equation. All the values were expressed as mean ± standard error of mean 
(SE) for 4 replicates of the experiments. 
Conflict  of interest  
The authors have no conflict of interest to declare.
 
RESULTS 
A. com inia aqueous extract inhibited the enzymatic activity of PTP1B in a 
concentration dependent manner. The mean inhibitory concentration (IC50) values 
was 0.69 µg/mL (Ki 0.26 (± 0.025 µg/mL) (Fig. 1).

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Ten fractions from the A. com inia aqueous extract were screened against PTP1B; 
seven were identified as possible PTP1B inhibitors. Figure 2 shows that when tested 
at a concentration of 100 µg/mL (n= 3), fraction 1 appeared to have no effect on 
the activity of this enzyme, fractions 2 and 3 showed only a small inhibition of 
PTP1B activity. Fractions 4, 7 and 8 exhibited a moderate inhibition of this protein, 
whereas fractions 5, 6, 9 and 10 showing the most apparent potent effect on PTP1B 
inhibition. The percentages of inhibition values in decreasing order: F9 (90.7 %), 
F6 (89.3 %), F10 (88.7 %), F5 (84.0 %), F7 (72.9 %), F4 (72.7 %), F8 (68.3 %), 
F2 (40.0 %), F3 (33.0 %).


 
Figure 3 (A, B, C, D, E and F) shows dose-response curves of the more active 
fractions, obtained from the aqueous extract of A. com inia leaves, on enzymatic 
activity of PTP1B. The graphs show that PTP1B inhibitory activity increased in a 
dependent manner of the fractions concentration, reaching inhibition values close to 
100 % at the maximum concentration tested (300 µg/mL). Differences were found 
in the IC50 values among different fractions. The more active fractions, AcF9 and 
AcF10, appeared to be related to increasing polarity, which gave IC50 values of  
4.4 µg/mL and 3.8 µg/mL (Ki 1.7 and 1.4 µg/mL) respectively. 
A. com inia aqueous extract inhibited the enzymatic activity of DPPIV in a 
concentration dependent manner, reaching 50 % percentage of inhibition values 
around the highest concentration tested of 300 ǋg/mL (Fig. 4). 
Figure 5 shows that fractions 6, 9 and 10 exhibited moderate inhibition of DPPIV 
activity, resulting fraction 6 the most active fraction in this assay; while the other 
fractions showed a slight inhibition of this protein. The percentage of inhibition 
values in decreasing order were: F6 (52.0 %), F10 (40.0 %), F9 (39.0 %), F7  
(32.0 %), F8 (31.0 %), F5 (26.0 %), F3 (25.0 %), F4 (23.0 %), F1 (18.0 %),  
F2 (17.0 %).
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DI SCUSSI ON  
The PTP1B and DPPIV inhibition assays were used in the present study to elucidate 
the type 2 antidiabetic mechanism of action of the A. com inia aqueous extract. 
In line with the present research, other plant extracts have shown inhibitory effect 
on PTP1B enzymatic activity in the same range of concentrations as the A. com inia 
aqueous extract. Thus, the methanolic extract of Psidium  guajava displayed a 
significant inhibitory effect of 87 % against PTP1B at a concentration of 30 ǋg/mL.14 
Other authors have reported that the methanolic extract of dried roots of Salvia 
m ilt iorrhiza exhibited a significant inhibitory effect on the activity of this enzyme.15 
The differences in the polarity of the solvents used in the mobile phase during 
fractionation process of A. com inia extract tends to bring out varieties of 
compounds in the diverse fractions. Hence, the inhibitory activity on PTP1B across 
the fractions indicates that different types of compounds are able to act as 
inhibitors of this enzyme. 
It has also been previously reported that PTP1B can be inhibited by different types 
of secondary metabolites from plants. A study reported that several types of 
compounds isolated from the plant Ardisia japonica: oleanolic acid, quercitrin and 
norbergenin showed a moderate inhibitory activity on this enzyme.16 Other authors 
have reported that three diterpene compounds obtained from methanolic extract of 
dried roots of Salvia m ilt iorrhiza as responsible for this effect which exhibited 
noncompetitive inhibition of PTP1B activity with IC50 values of 11.4 ± 0.6 mM,  
22.4 ± 0.6 mM and 56.1 ± 6.3 mM, respectively.15 Additional work found that 
triterpenes isolated from the methanol extract of Diospyros kaki (Persimmon) 
leaves had an inhibitory effect on the activity of PTP1B enzyme with IC50 values in 
the range of 3.1 ± 0.2 to 18.8 ± 1.3 mM.17 It was also reported that a proteoglycan 
obtained from the fruit of Ganoderma lucidum , showed efficient PTP1B inhibitory 
potency with an IC50 value of 5.12 ± 0.05 ǋg/mL.2 
The fraction 6 (butanolic fraction) from A. com inia resulted one of the more active 
fraction in the PTP1B inhibition. This result correspond with data refered in other 
papers, which informed that the butanolic fraction from methanolic extract of 
Psidium  guajava containing the active entity with an IC50 value of 2.6 ǋg/mL.14 
Unpublished studies demonstrated recently the AcF6 contains flavonoids, which are 
the secondary metabolites responsible of the PTP1B inhibition. Thus, quercitrin and 
norbergenin isolated from Ardisia japonica showed a moderate inhibitory activity on 
this enzyme with IC50 values of 24 ǋM and 28 ǋM respectively.16 
The fractions 9 and 10 were the most active fractions in this assay. Unpublished 
results about chemical characterization of them indicated that contained tannins, 
which was previously demonstrated for A. com inia aqueous extract,11 although 
further experiments are necessary in order to dilucidated their chemical structure. 
Other authors confirm the importance of tannins in the PTP1B inhibitory effect, 
comparing results of total methanolic extract and detannificated extract of 
Cichorium  intybus, demonstrated that tannins are responsible component of this 
pharmacological effect.18 
Previous studies have shown that PTP1B enzyme has two active sites: a catalytic site 
and an allosteric site. X-ray diffraction has identified the interactions between PTP1B 
and allosteric inhibitors.19 A general mechanism proposed for other proteins tyrosine 
phosphatases is that allosteric inhibitors prevent the formation of the enzymes active 
form, blocking the WPD loop mobility in the catalytic site, which closure is essential 
for catalytic activity of the enzyme.20 Hansen, et  al., 2005 reported that the allosteric 
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inhibition of PTP1B activity can be achieved by selective modification of cysteine 
residues, Cys 121, which although not located in the catalytic site, providing 
interactions with residues which are in contact with the His 214, which has been 
shown to be important for catalysis.21 Thus, the amentoflavone obtained from 
Selaginella tam ariscina, a biflavonoide, inhibited PTP1B activity by allosteric 
inhibition.19 Further work to determine whether the potentially active fractions of A. 
com inia are working at the catalytic or an allosteric site. 
Consistent with the results in this study, many other papers have reported 
inhibition of DPPIV enzymatic activity by plant extracts: the aqueous extract from 
Cistus incanus L. leaves,22 the methanolic extract of Mangifera indica leaves,23 the 
aqueous extracts of plants native of Armenia which cited cloves, cinnamon, green 
and black tea being highly effective, blackberry leaves, melilot, oregano and sea-
buckthorn which behaved as inhibitors of this enzyme, in combination with other 
antidiabetic drugs.24 In addition, the hexane extract of Annona squam osa inhibited 
DPP-IV at 30 mg/mL.25 
DPP-IV is a 766-amino acid transmembrane glycoprotein consisting of three parts, 
a cytoplasmic tail, a trans-membrane region and an extracellular part.  
The extracellular part is divided into a catalytic domain and an eight-bladed ǃ-
propeller domain. The latter contributes to the inhibitor binding site which consists 
of a deep lipophilic pocket combined with several exposed aromatic side chains 
achieving high affinity for small molecule binding. DPP-IV inhibitors usually have an 
electrophilic group that can interact with the hydroxyl of the catalytic serine in the 
active binding site. DPP-IV inhibitors without the electrophilic group have shown 
toxicity due to affinity to other dipeptidyl peptidases, such as: DPP-2, DPP-8 and 
DPP-9.26 
The secondary metabolites responsible of the DPPIV inhibition may be the 
flavonoids present in the A. com inia aqueous extract which existence was recently 
demonstrated in unpublished studies. This type of compound probably is present in 
the most active fraction (AcF6), but further experiments are necessary for 
confirmation it. Thus, an article describes the antidiabetic effect of the flavonoid 
rich fraction of Pilea m icrophylla (L.) inhibited dipeptidyl peptidase IV (DPP-IV) in 
vit ro with an IC50= 520.4 ± 15.4 ǋg/mL.27 
Further studies will be necessary in order to corroborate these effects on in vivo 
models of type 2 diabetes. Also it will be important to approach toxicological studies 
of the active fractions in order to demonstrate the safety of them. 

CONCLUSI ON  
In our in vit ro research, A. com inia aqueous extract, in particular its polar fractions 
(AcF9 and AcF10) have promissory antidiabetic properties mediated by PTP1B and 
DPPIV, relevant therapeutic targets for type 2 diabetes. 
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